Tesi Raymond Joseph — SEC Form 4 filings

SEC reporting owner CIK 1767280. 6 Form 4 filings on record with FilingPulse; latest filed 2024-12-09.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-04-23 to 2024-12-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Inmune Bio, Inc. (INMB)President and CEO, Director, 10% owner62 legs · 33,408 sh · $248,0407

Form 4 filings — Tesi Raymond Joseph

FiledFormIssuerReported transactionsSource
2024-12-094Inmune Bio, Inc. (INMB)Grant/award (A): 226,000 (derivative) @ $0EDGAR
2024-09-164Inmune Bio, Inc. (INMB)Purchase (P): 15,380 @ $6.38 · Purchase (P): 15,380 (derivative) @ $0.12EDGAR
2024-06-124Inmune Bio, Inc. (INMB)Grant/award (A): 37,882 (derivative) @ $0EDGAR
2024-05-164Inmune Bio, Inc. (INMB)Grant/award (A): 160,000 (derivative) @ $0EDGAR
2024-04-244/AInmune Bio, Inc. (INMB)Purchase (P): 18,028 @ $8.32 · Purchase (P): 18,028 (derivative) @ $0.12EDGAR
2024-04-234Inmune Bio, Inc. (INMB)Grant/award (A): 18,028 @ $8.32 · Grant/award (A): 18,028 (derivative) @ $0.12EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1767280 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →